Exploring the patent landscape and innovation of hydrogel-based bioinks used for 3D bioprinting.

A. Fatimi
{"title":"Exploring the patent landscape and innovation of hydrogel-based bioinks used for 3D bioprinting.","authors":"A. Fatimi","doi":"10.2174/2667387816666220429095834","DOIUrl":null,"url":null,"abstract":"BACKGROUND\nThis paper provides a comprehensive overview of the patent situation for hydrogel-based bioinks used for 3D bioprinting globally. It encapsulates information which could be used as a reference by researchers in the fields of 3D bioprinting, biomaterials, tissue engineering, and biomedical engineering, as well as those interested in biomaterials, especially in the formulation of hydrogels. It can also inform policy discussions, strategic research planning, or technology transfer in this area. The findings presented hereinafter are considered novel research aspects regarding the used hydrogels, their preparation methods, and their formulations, as well as the 3D bioprinting process using hydrogels. Furthermore, the novel part, synthesized patents, is regarded as a breakthrough in hydrogel-based bioinks.\n\n\nMETHODS\nThe following research aspects of this study are based on data collection from selected patent databases. The search results are then analyzed according to publication years, classification, inventors, applicants, and owners, as well as jurisdictions.\n\n\nRESULTS\nBased on the earliest priority date, it is possible to precisely assume that 2004 is considered the starting year of patenting of hydrogel-based bioinks. Furthermore, 2020 was the year with the most patent documents. According to the findings, the United States, China, and the Republic of Korea are the most prolific countries in terms of patenting on hydrogel-based bioinks. The most prolific patenting companies are from the United States, Sweden, and Australia, while universities from the Republic of Korea and the United States are the academic institutions leading the way. Most inventions of hydrogel-based bioinks intended for hydrogels or hydrocolloids used as materials for prostheses or for coating prostheses are characterized by their function or physical properties.\n\n\nCONCLUSION\nThe state has been reviewed by introducing what has been patented concerning hydrogel-based bioinks. Knowledge clusters and expert driving factors indicate that the research based on biomaterials, tissue engineering, and biofabrication is concentrated in the most common patent documents. Finally, this paper, which gives a competitive analysis of the past, present, and future trends in hydrogel-based bioinks, leads to various recommendations that could help one to plan and innovate research strategies.","PeriodicalId":20955,"journal":{"name":"Recent advances in drug delivery and formulation","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2022-04-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"13","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Recent advances in drug delivery and formulation","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2174/2667387816666220429095834","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 13

Abstract

BACKGROUND This paper provides a comprehensive overview of the patent situation for hydrogel-based bioinks used for 3D bioprinting globally. It encapsulates information which could be used as a reference by researchers in the fields of 3D bioprinting, biomaterials, tissue engineering, and biomedical engineering, as well as those interested in biomaterials, especially in the formulation of hydrogels. It can also inform policy discussions, strategic research planning, or technology transfer in this area. The findings presented hereinafter are considered novel research aspects regarding the used hydrogels, their preparation methods, and their formulations, as well as the 3D bioprinting process using hydrogels. Furthermore, the novel part, synthesized patents, is regarded as a breakthrough in hydrogel-based bioinks. METHODS The following research aspects of this study are based on data collection from selected patent databases. The search results are then analyzed according to publication years, classification, inventors, applicants, and owners, as well as jurisdictions. RESULTS Based on the earliest priority date, it is possible to precisely assume that 2004 is considered the starting year of patenting of hydrogel-based bioinks. Furthermore, 2020 was the year with the most patent documents. According to the findings, the United States, China, and the Republic of Korea are the most prolific countries in terms of patenting on hydrogel-based bioinks. The most prolific patenting companies are from the United States, Sweden, and Australia, while universities from the Republic of Korea and the United States are the academic institutions leading the way. Most inventions of hydrogel-based bioinks intended for hydrogels or hydrocolloids used as materials for prostheses or for coating prostheses are characterized by their function or physical properties. CONCLUSION The state has been reviewed by introducing what has been patented concerning hydrogel-based bioinks. Knowledge clusters and expert driving factors indicate that the research based on biomaterials, tissue engineering, and biofabrication is concentrated in the most common patent documents. Finally, this paper, which gives a competitive analysis of the past, present, and future trends in hydrogel-based bioinks, leads to various recommendations that could help one to plan and innovate research strategies.
探索用于3D生物打印的水凝胶生物墨水的专利景观和创新。
本文对全球用于生物3D打印的水凝胶基生物墨水的专利情况进行了全面概述。它包含的信息可供3D生物打印、生物材料、组织工程和生物医学工程领域的研究人员以及对生物材料,特别是水凝胶配方感兴趣的研究人员参考。它还可以为该领域的政策讨论、战略研究规划或技术转让提供信息。以下提出的研究结果被认为是关于所使用的水凝胶,其制备方法和配方以及使用水凝胶的3D生物打印过程的新研究方面。此外,合成专利的新部分被认为是水凝胶基生物墨水的突破。方法本研究的以下研究方面是基于选定的专利数据库的数据收集。然后根据出版年份、分类、发明者、申请人和所有者以及司法管辖区对搜索结果进行分析。结果根据最早的优先权日期,可以准确地假设2004年是水凝胶基生物墨水专利的起始年。此外,2020年是专利文件最多的一年。根据研究结果,美国、中国和韩国是申请水凝胶生物墨水专利最多的国家。申请专利最多的公司来自美国、瑞典和澳大利亚,而韩国和美国的大学则是领先的学术机构。大多数水凝胶基生物墨水的发明用于作为假体或涂层假体材料的水凝胶或水胶体,其特征在于其功能或物理性质。结论综述了我国水凝胶基生物墨水的专利情况。知识集群和专家驱动因素表明,基于生物材料、组织工程和生物制造的研究集中在最常见的专利文件中。最后,本文对水凝胶生物墨水的过去、现在和未来趋势进行了竞争性分析,提出了各种建议,可以帮助人们规划和创新研究策略。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信